Support pressure at $47.77: Can BSX avoid deeper losses?

Traders Union
All News
Stocks
Boston Scientific slides 4.35% today

Highlights

BSX/USD trades below key moving averages across all timeframes as sustained selling pressure dominates the trend.
Momentum and volatility indicators align to show strong downside pressure, with momentum readings and oscillators in oversold territory.
Price ended at $49.75 after falling 4.35%, with a projected short-term range of $47.77 to $50.83 and a 70% probability of further decline.

Bearish momentum persists as multiple indicators confirm selling

On the technical front, BSX is trading below the MA-20 ($51.19) and MA-50 ($51.48) on the hourly chart, and also remains under the MA-200 ($69.93) on the daily chart. Immediate resistance is marked by the Ichimoku Kijun level at $51.16. Momentum indicators reflect ongoing bearishness: both MACD and ADX are showing sell signals, RSI stands at 34.5 in sell territory, and Stoch RSI and CCI readings are deeply oversold. Additionally, Bull/Bear Power is negative, and the Awesome Oscillator confirms predominant selling pressure.

Downside bias prevails as resistance and support levels define risk

In the short term, BSX is expected to trade within a band of $47.77 to $50.83, as typical volatility persists. There is a 30% probability of an upward move, with the downside scenario favored at 70%. Should the price break above the $51.16 resistance, higher levels may be tested, while a dip below the $47.77 support could open the way for further declines.

Viktoras Karapetjanc, expert at Traders Union, sees ongoing pressure for Boston Scientific as technical signals remain downbeat. The bearish tone is driven almost entirely by market sentiment as no company-specific news is present. Macro factors may continue to weigh on medical technology names in the near term. However, he maintains a constructive outlook given the high volatility and potential for a reversal if resistance at $51.16 is broken. "If the price can reclaim the $51.16 level, bulls could regain control — I am patient but cautiously optimistic here."

Earlier, analysts noted that Boston Scientific was showing mixed momentum, with short-term bullish signals overshadowed by persistent long-term technical weakness. The latest action confirms and intensifies this outlook as continued selling pressure pushes BSX firmly below key moving averages, highlighting the importance of closely watching the $47.77 support level for any further downside risk.

Source of Data: BSX Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.